United Biomedical Inc - Nov 10, 2021 Form 3 Insider Report for Vaxxinity, Inc. (VAXX)

Role
10%+ Owner
Signature
/s/ Mei Mei Hu, As Director and Officer
Stock symbol
VAXX
Transactions as of
Nov 10, 2021
Transactions value $
$0
Form type
3
Date filed
11/10/2021, 03:58 PM
Next filing
Nov 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VAXX Class A common stock 51.3M Nov 10, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VAXX Series A preferred stock Nov 10, 2021 Class A common stock Direct F2
holding VAXX Series A preferred stock Nov 10, 2021 Class A common stock See Note F1, F3
holding VAXX Warrant Nov 10, 2021 Class A common stock See Note F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.
F2 The 384,410 shares of Series A preferred stock will convert into 247,050 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series A preferred stock.
F3 The 6,554,643 shares of Series A preferred stock will convert into 4,212,495 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series A preferred stock.
F4 Represents 1,928,020 shares of Class A common stock underlying a warrant. The warrant is currently exercisable and has an exercise price of $12.45.